This was particularly obvious at the interface between normal ducts and tumour tissue, where ductal expression of FBLN2 was lost in regions of DCIS/invasive carcinoma (Fig. 6c,d). The gene discussed is FBLN2; the disease is ductal breast carcinoma in situ.